INTRADIGM CORPORATION
Private biotechnology company that develops systematic RNA interference (RNAi) therapeutics for the treatment of serious diseases with an initial focus on oncology. The company's expertise in drug development and delivery serves as the foundation of Intradigm RNAi platform. In particular, the company proprietary RNAi Nanoplex delivery technology is unique in its ability to enable the targeted delivery of RNAi therapeutics to specific tissues through systemic administration of the drug product.
INTRADIGM CORPORATION
Industry:
Biotechnology Health Care Therapeutics
Founded:
2000-01-01
Address:
Palo Alto, California, United States
Country:
United States
Website Url:
http://www.intradigm.com
Total Employee:
11+
Status:
Closed
Contact:
(650) 855 9696
Total Funding:
37.4 M USD
Technology used in webpage:
Domain Not Resolving
Investors List
Novartis Venture Fund
Novartis Venture Fund investment in Series B - Intradigm Corporation
MediBIC Group
MediBIC Group investment in Series B - Intradigm Corporation
Roche Venture Fund
Roche Venture Fund investment in Series B - Intradigm Corporation
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Series B - Intradigm Corporation
Astellas Venture Management
Astellas Venture Management investment in Series B - Intradigm Corporation
MP Healthcare Venture Management
MP Healthcare Venture Management investment in Series B - Intradigm Corporation
Lilly Ventures
Lilly Ventures investment in Series B - Intradigm Corporation
Alta Partners
Alta Partners investment in Series B - Intradigm Corporation
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Series A - Intradigm Corporation
Alta Partners
Alta Partners investment in Series A - Intradigm Corporation
Official Site Inspections
http://www.intradigm.com
- Host name: a904c694c05102f30.awsglobalaccelerator.com
- IP address: 13.248.169.48
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
